Victory Capital Management
EVH icon

Victory Capital Management’s Evolent Health EVH Stock Holding History

Victory Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.7K Sell
11,728
-127
-1% -$403 ﹤0.01% 2362
2025
Q4 		$47.4K Sell
11,855
-1,306
-10% -$7.26K ﹤0.01% 2334
2025
Q3 		$111K Sell
13,161
-491
-4% -$4.76K ﹤0.01% 2287
2025
Q2 		$154K Sell
13,652
-153
-1% -$1.41K ﹤0.01% 2281
2025
Q1 		$131K Sell
13,805
-28
-0.2% -$283 ﹤0.01% 2279
2024
Q4 		$156K Sell
13,833
-215
-2% -$3.78K ﹤0.01% 2277
2024
Q3 		$397K Sell
14,048
-241
-2% -$6.21K ﹤0.01% 2071
2024
Q2 		$273K Sell
14,289
-414,447
-97% -$10.6M ﹤0.01% 2124
2024
Q1 		$14.1M Sell
428,736
-228,782
-35% -$7.3M 0.01% 939
2023
Q4 		$21.7M Sell
657,518
-127,843
-16% -$3.62M 0.02% 744
2023
Q3 		$21.4M Sell
785,361
-197,089
-20% -$5.48M 0.02% 730
2023
Q2 		$29.8M Sell
982,450
-181,714
-16% -$5.88M 0.03% 608
2023
Q1 		$37.8M Sell
1,164,164
-105,820
-8% -$3.35M 0.04% 539
2022
Q4 		$35.7M Buy
1,269,984
+242,088
+24% +$6.94M 0.04% 577
2022
Q3 		$36.9M Buy
1,027,896
+572,503
+126% +$20.2M 0.04% 573
2022
Q2 		$14M Buy
455,393
+425,953
+1,447% +$12.4M 0.02% 953
2022
Q1 		$810K Buy
29,440
+81
+0.3% +$2.12K ﹤0.01% 1914
2021
Q4 		$812K Sell
29,359
-5,303
-15% -$152K ﹤0.01% 1927
2021
Q3 		$1.07M Buy
34,662
+11,260
+48% +$270K ﹤0.01% 1830
2021
Q2 		$494K Buy
23,402
+11,233
+92% +$225K ﹤0.01% 2213
2021
Q1 		$246K Sell
12,169
-333
-3% -$6.33K ﹤0.01% 2469
2020
Q4 		$200K Buy
12,502
+1,478
+13% +$19.5K ﹤0.01% 2375
2020
Q3 		$137K Sell
11,024
-1,767
-14% -$20.8K ﹤0.01% 2324
2020
Q2 		$91K Sell
12,791
-14,799
-54% -$99.1K ﹤0.01% 2364
2020
Q1 		$150K Buy
27,590
+12,564
+84% +$112K ﹤0.01% 2408
2019
Q4 		$136K Buy
15,026
+3,810
+34% +$31K ﹤0.01% 2430
2019
Q3 		$81K Buy
+11,216
New +$80.5K ﹤0.01% 2502

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's EVH Position: Q1 2026 in Review

Victory Capital Management reduced its Evolent Health (EVH) stake by 1.1% in Q1 2026, selling an estimated $403 and leaving 11,728 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2362.

Victory Capital Management first reported a position in EVH in Q3 2019 and has held it in 27 quarters since. The position peaked at $37.8M in Q1 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Victory Capital Management held 11,728 shares of Evolent Health worth $26.7K as of Q1 2026.
  • Victory Capital Management sold 127 Evolent Health shares in Q1 2026, an estimated $403.
  • Evolent Health made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2362 holding.
  • Victory Capital Management first reported a position in Evolent Health in Q3 2019 and has held it in 27 quarters since.
  • Victory Capital Management's Evolent Health position peaked at $37.8M in Q1 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.